Magenta Therapeutics, Inc. Profile Avatar - Palmy Investing

Magenta Therapeutics, Inc.

Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 ant…

Biotechnology
US, Cambridge [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of MGTA's Analysis
CIK: - CUSIP: 55910K108 ISIN: US55910K1088 LEI: - UEI: -
Secondary Listings
MGTA has no secondary listings inside our databases.